Table 2 Themes evaluated and retained for the Delphi survey

1

First episode psychosis

2

Acute exacerbation or relapse of psychosis

3

Agitation (intramuscular injection)

4

Long-term maintenance therapy

5

Onset of cardiovascular or metabolic disorders

6

Onset of hyperprolactinemia or sexual disorders

7

Occurrence of cognitive disorders

8

Secondary negative symptoms

9

Partial response (other than resistant schizophrenia)

10

Addictive comorbidity

11

Resistant schizophrenia in association with clozapine

12

Resistant schizophrenia as monotherapy

13

Resistant schizophrenia in association (without clozapine)

14

Pregnancy